SARS-CoV-2 Takes the Bait: Exosomes As Endogenous Decoys
Authors
Affiliations
Writing in PLOS Biology, Ching and colleagues show that ACE2-decorated exosomes are deployed as natural inhibitory decoys against SARS-CoV-2. High decoy levels correlate with improved patient outcomes, suggesting they directly help COVID-19 recovery and supporting the concept of successful future decoy-based therapies.
Oncoviral Infections and Small Extracellular Vesicles.
Wazny L, Whiteside T, Pietrowska M Viruses. 2024; 16(8).
PMID: 39205265 PMC: 11359865. DOI: 10.3390/v16081291.
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity.
Lv X, Chen R, Liang T, Peng H, Fang Q, Xiao S mBio. 2024; 15(3):e0335823.
PMID: 38303107 PMC: 10936183. DOI: 10.1128/mbio.03358-23.
Nanoscale Phytosomes as an Emerging Modality for Cancer Therapy.
Kadriya A, Falah M Cells. 2023; 12(15).
PMID: 37566078 PMC: 10417745. DOI: 10.3390/cells12151999.